Navigation Links
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Date:1/3/2012

SAN DIEGO, Jan. 3, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on December 22, 2011 the Compensation Committee of its Board of Directors approved the grant of inducement stock options to purchase an aggregate of 39,625 shares of common stock to 4 new employees.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Each stock option has an exercise price per share equal to $12.24 the fair market value on December 30, 2011, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and 1/48 of the shares vesting monthly thereafter, subject to the new employee's continued service relationship with the Company. Each stock option was effective as of December 30, 2011, and also has a ten year term and is subject to the terms and conditions of the Company's 2006 Equity Incentive Plan and the stock option agreement pursuant to which the option was granted.

The stock options were granted as inducements material to the new employees entering into employment with Optimer in accordance with NASDAQ Listing Rule 5635(c)(4).

About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed and commercialized DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). Optimer has also received marketing authorization for fidaxomicin tablets in the European Union under the trade name DIFICLIR™. The company is seeking marketing authorization for fidaxomicin i
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
2. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
3. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
4. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
5. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
6. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
8. Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
9. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
10. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "North American Active Wound ... Application (Surgical Wound, & Ulcer), by End-User (In-Patient, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... is estimated to grow at a CAGR of ...
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3
... Mass., June 2, 2011 Syndax Pharmaceuticals, a ... the United States Patent and Trademark Office of ... METHOXYCARBONYL—AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."   This follows the ... 2010 adding to the extensive patent estate. ...
... CARLSBAD, Calif., June 2, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... announced that management will present a company overview at Jefferies, ... 11:30 a.m. ET at the Grand Hyatt, New York. ... available on the "Investors & Media" section of the Company,s ...
Cached Medicine Technology:Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:5/22/2015)... Mountain Point Medical Center, a campus of Jordan ... Friday, May 29, 2015 at 11 a.m., followed by a ... medical center, set to officially open on June 1, 2015, ... , “The opening of Mountain Point Medical Center is ... community,” said Kent Loosle, CEO of Mountain Point Medical Center. ...
(Date:5/22/2015)... York, New York (PRWEB) May 22, 2015 ... http://www.xareltolawsuit2015.com/ ) filed on behalf of individuals who ... due to its use continue to move forward ... Louisiana. According to a Pretrial Order dated May ... the preservation of documents and electronically stored information. ...
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
(Date:5/22/2015)... May 22, 2015 Hands On HealthCare ... 17, 2015, the Annual One Day Sale on ... Hands On HCMT offers drastically reduced certificates one day a ... have enough sessions, through what used to be the slowest ... for the community as well. This once a year occurrence ...
(Date:5/22/2015)... 22, 2015 Family, friends, students, colleagues, ... surgical oncologist, Dr. LaSalle D. Leffall, on Monday, May ... began after Grand Rounds in the hospital’s Tower Auditorium. ... outside the auditorium, trying to keep the secret. “I’d ... he sees me, he’ll know something is up,” she ...
Breaking Medicine News(10 mins):Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... schizophrenia, there is a pattern of cognitive difficulties they ... memory, attention and processing speed. Drawing on a ... from 1972 to 1973, a team led by Duke ... that first appeared when adult study subjects with schizophrenia ...
... A tiny new sensor could provide fresh, inexpensive ... variety of diseases. University of Florida engineers have ... ranging from monitoring diabetics, glucose levels via their breath ... They say early results are promising particularly considering ...
... a significantly higher risk of relapse attacks in patients with ... to a study conducted by researchers from the University of ... that vitamin D insufficiency is a risk factor for developing ... vitamin D levels influence the disease course of those who ...
... for Disease Control has launched an influenza genome sequencing ... virus has evolved in British Columbia, and may continue ... capitalizes on BC,s expertise and capacity in genome sequencing ... viruses collected in British Columbia during the H1N1 pandemic, ...
... experiencing chest pain who had electrocardiogram (ECG or EKG) ... significantly reduced time-to-treatment or door-to-balloon (D2B) time. When ... the subjects in the field, the mean D2B time ... ECGs. This advanced assessment significantly reduced D2B by ...
... , Housewife Hits South Florida! ... Lisa Wu Hartwell , one of the stars of the ... to Boca Raton, Florida .   She isn,t coming to ... of viewers. , (Photo: http://www.newscom.com/cgi-bin/prnh/20100120/DC41252 ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20100120/DC41252LOGO ...
Cached Medicine News:Health News:Team finds childhood clues to adult schizophrenia 2Health News:Team finds childhood clues to adult schizophrenia 3Health News:Engineers: New sensor could help treat, combat diabetes, other diseases 2Health News:Low vitamin D levels associated with greater risk of relapse in childhood-onset multiple sclerosis 2Health News:Low vitamin D levels associated with greater risk of relapse in childhood-onset multiple sclerosis 3Health News:Genomic surveillance of pandemic H1N1 2Health News:Heart attack victims who have ECGs in the field experience shorter time-to-treatment 2Health News:Bravo's 'Real Housewife' Comes to Boca Raton, Florida 2
... first cobalt chromium stent for small vessels. ... have remarkably thin struts and a low ... deliverable stent. Less metal, less injury ... vessel treatment. The Guidant MULTI-LINK MINI VISION ...
... an ophthalmologic medical device designed for the ... to -3.00 diopters.* When placed in the ... optical zone, the product reshapes the anterior ... composed of two prescription inserts, each having ...
... Heartline™ system is winning the hearts of ... "Remaining calm are the operative words for ... the same time they and their attending ... any change in their heart condition is ...
... Weights offer the physician a new approach to ... paralysis. The weight simply uses gravity to gently ... down, or when the eyelid muscle is relaxed. ... a variety of skin tone colors to match ...
Medicine Products: